LA
LH icon

Legacy Advisors’s Labcorp LH Stock Holding History

Legacy Advisors’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-222
Closed -$33K – 228
2019
Q2 		$33K Buy
+222
New +$31K 0.02% 228

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MCM
Melvin Capital Management New York $9.86B AUM 16.31% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Legacy Advisors's LH Position: Q3 2019 in Review

Legacy Advisors sold out of Labcorp (LH) in Q3 2019, closing a stake of 222 shares — an estimated $33K sold.

Legacy Advisors first reported a position in LH in Q2 2019 and held it in 1 quarter. The position peaked at $33K in Q2 2019. 738 funds tracked by Wall St. Rank hold LH as of Q3 2019.

  • Legacy Advisors reported no remaining Labcorp position as of Q3 2019 after selling out during the quarter.
  • Legacy Advisors sold 222 Labcorp shares in Q3 2019, an estimated $33K.
  • Legacy Advisors first reported a position in Labcorp in Q2 2019 and held it in 1 quarter.
  • Legacy Advisors's Labcorp position peaked at $33K in Q2 2019.
  • 738 funds tracked by Wall St. Rank held Labcorp as of Q3 2019.

Based on Legacy Advisors's 13F filing for Q3 2019, filed 10 Oct 2019.